iKanekt Biomedical Technologies
Problem Solution Market Technology Team Get in Touch
Next-Gen ICU & Emergency Room Intelligence

Saving Time.
Saving Lives. Reimagining Emergency Care.

iKanekt Biomedical Technologies is building the world's first smart sensing endotracheal tube — detecting airway obstruction in real time, before hypoxia occurs, without changing clinical workflow.

Explore iSense ETB → Investor Enquiry
₹870Cr
India TAM / year
0
Direct competitors
TRL 3
Current stage
IP Filed
Patent No. 202341037184
■ iSense ETB Monitor — Live Feed
Sensor 1
92%
Sensor 2
63%
Sensor 3
88%
Airway Clear Zone 2: Secretion ↑

// 01 — The Problem

A critical blind spot
in ICU airway management

Endotracheal tubes are used millions of times every year. Yet they remain entirely passive — providing zero real-time data about what's happening inside the airway.

Passive Devices, Zero Insight

Standard ETTs have no sensors, no monitoring capability, and no way to detect obstruction until the patient deteriorates.

Late Detection is Dangerous

Obstructions from secretions, mucus plugs, blood, or tube kinking only manifest through secondary events — sudden desaturation, raised airway pressures, or ventilator alarms.

No Solution Exists

There is currently no widely adopted device that continuously monitors the ETT lumen, detects early secretion ingress, or quantifies partial blockage without altering ICU workflow.

20–30%
ICU patients experience ETT blockage
10–15%
Reintubation rate with standard tubes
7–10
Average ICU days per ventilated patient
₹2L+
Average cost per complex ICU patient

// 02 — The Solution

iSense ETB — Intelligence
built into every breath

A sensor-enabled endotracheal tube that provides real-time airway obstruction monitoring — identical in form and use to a standard ETT. Zero workflow change. Zero learning curve.

🔬

Embedded Optical Sensors

Non-contact optical LED–photodiode modules integrated within the tube wall at 3 sensing zones. No electronics in contact with patient tissue.

Core Technology
📡

Real-Time Obstruction Detection

Continuously detects and quantifies partial lumen obstruction (30%, 50%, >70%), secretion ingress including Murphy's eye, and tube kinking.

Clinical Capability
⚡

Early Warning Before Hypoxia

Visual and audible alerts fire before physiological deterioration — giving clinicians actionable time to suction or intervene.

Safety First
📍

Obstruction Localisation

Indicates the approximate location of obstruction along the tube, enabling faster, more targeted clinical response.

Spatial Intelligence
🔄

Zero Workflow Change

Standard ETT form factor. Same intubation protocol. Single-use disposable tube plus reusable bedside monitor — no complexity added.

Adoption Ready
🛡️

Failsafe Design

If the sensor technology fails, the device continues to function as a fully standard ETT. The sensing is additive, never intrusive.

Safety Architecture

// 03 — Clinical Value

Measurable impact across
every ICU dimension

Metric Baseline (Standard ETT) Target (iSense ETB) Improvement
ETT Blockage Rate 20–30% <5% ↓ ~83%
ICU Length of Stay 7–10 days 5–7 days ↓ 2–3 days
Reintubation Rate 10–15% <5% ↓ ~67%
Ventilator-Associated Events High baseline Significantly lower ↓ 30–50%
Cost per ICU Patient ₹1.5–2 Lakhs ₹1.2–1.5 Lakhs ↓ ~25%

// 04 — Market Opportunity

A large, recurring market with
no direct competition

India consumes over one crore endotracheal tubes annually. iSense ETB targets the highest-risk, highest-value ICU segment — where the clinical case is strongest.

TAM
Total Addressable Market
~₹870 Cr
Per year · India
ICU ventilation segment (₹293 Cr) plus general anaesthesia surgeries (₹576 Cr) at ₹800 ASP across 1Cr+ annual tube uses.
SAM
Serviceable Available Market
₹300–450 Cr
Per year · ICU-focused
Mechanically ventilated ICU patients, long surgeries, tracheostomy patients — where iSense ETB delivers the strongest clinical value.
SOM
Serviceable Obtainable Market
₹40–70 Cr
Annual revenue · Mid-term
Tier-1 & Tier-2 hospitals, 10–15% ICU tube adoption, 4–5 year ramp. Excludes monitor sales, premium pricing & international markets.
USD 2.14BGlobal ETT market 2025
6.4%CAGR 2025–2030
USD 2.92BGlobal forecast by 2030
0Direct Indian competitors with tech integration

// 05 — Technology

Proven sensing architecture,
ready to scale

iSense ETB uses embedded optical LED–photodiode pairs within the tube wall to non-invasively sense the internal lumen in real time. A multichannel connector links the disposable tube to a reusable bedside monitor displaying waveforms, patency percentages, and anatomical obstruction maps.

Manufacturing uses medical-grade PVC already accepted for ETTs. Sensor integration occurs within the tube wall, preserving airway patency and aligning with existing ETT supply chains.

Technology Readiness Level (TRL)
Currently at TRL 3 · Targeting TRL 4–5 by Q4 2026
🏅 Intellectual Property
Patent Application No. 202341037184 · Filed in India
Version 1 — Proof of Concept TRL 2
6.5mm standard ETT with proximity sensor at 3 positions
Animal blood with heparin used to simulate secretions
Confirmed: secretion passage is detectable and actionable
Real-time sensor graph validated signal movement
Version 2 — Prototype V01 TRL 3
Custom ETT + flexible PCB + data transmission cable
Optical LED–photodiode modules embedded in tube wall
Multichannel connector to external reusable monitor
Display: real-time waveforms, lumen patency 0–100%, anatomical reference, safety alerts
Validates core sensing architecture for TRL 4–5 progression

// 06 — Roadmap

Five phases to global market

1
Q3–Q4 2025
Prototype Validation
Bench testing, simulated ICU validation, intensivist feedback
2
Q1–Q4 2026
Regulatory & Pre-Clinical
Biocompatibility, safety tests, CDSCO/ISO documentation
3
Q1–Q3 2027
Clinical Evaluation
Pilot trials in 2–3 leading ICUs, safety & performance data
4
Q4 2027
Market Launch
Manufacturing scale-up, distributor onboarding, Tier-1 hospitals
5
Q1–Q4 2028
Expansion & Global
SE Asia & MEA export, CE/FDA certification, OEM licensing

// 07 — The Team

Clinical depth.
Engineering edge. Commercial drive.

Dr. D. Vimal Bhardwaj
Dr. D. Vimal Bhardwaj
Intensivist & Co-Founder
Consultant Intensivist · Mazumdar Shaw Medical Center, Narayana Health City, Bengaluru
10+ years in critical care with deep expertise in complex ICU management. Clinical validation lead for iSense ETB — ensuring product-market fit from day one.
Mr. Vajramuni Balaramaiah
Mr. Vajramuni Balaramaiah
Biomedical Engineer & Co-Founder
Scientist · Entrepreneur · Multiple patents in medical device innovation
Experienced biomedical engineer with a track record of breakthrough concepts and IP creation. Architects the core sensing technology and manufacturing strategy.
Mr. Srirang Ramamorthy
Mr. Srirang Ramamorthy
Entrepreneur & Co-Founder
15+ years in healthcare & life sciences
Specialises in medical device clinical validation and business development. Leads commercial strategy, investor relations, and go-to-market execution.
Ningku Lachungpa
Ningku Lachungpa
Strategic Operations
Cross-industry & international operations
A strategic operator with a strong track record of executing complex, high-impact initiatives in fast-growing environments. Her cross-industry and international experience brings a sharp perspective to building, scaling, and optimizing businesses.
Santhosh Sagar Reddy
Santhosh Sagar Reddy
Technology & Product
Co-founder · Multiple technology companies
Focused on helping growth-stage businesses scale through product-led transformation. Combines product thinking, engineering, and execution to deliver AI-driven solutions — shaped by early experience at ThoughtWorks.
// Partner With Us

Ready to back the
future of ICU safety?

We're seeking strategic investors and hospital partners to accelerate the path from prototype to clinical deployment. Reach out to learn more about the opportunity.

Contact the Team → Download Pitch Deck

Or email us directly at contact@ikanekt.com